Facial Plast Surg 2017; 33(01): 102-108
DOI: 10.1055/s-0037-1600525
Rapid Communication
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Mandibular Rim Trilogy with Botulinum Toxin Injection: Reduction, Projection, and Lift

Renpeng Zhou*
1   Department of Plastic and Reconstructive Surgery, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People's Republic of China
,
Benyun Pan*
1   Department of Plastic and Reconstructive Surgery, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People's Republic of China
,
Chen Wang
1   Department of Plastic and Reconstructive Surgery, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People's Republic of China
,
Danru Wang
1   Department of Plastic and Reconstructive Surgery, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People's Republic of China
› Author Affiliations
Further Information

Publication History

Publication Date:
22 February 2017 (online)

Abstract

“Onabotulinum toxin A (Botox) revolution” has brought the fundamental change in the facial rejuvenation as well as the concept of microinjection. The aesthetic standard tends to be the “globalization”; however, Asians have different aesthetic cultures and unique facial features compared with Caucasians. A new rejuvenation concept is proposed during our practice; the Asian face should preserve the original facial identity during Botox treatments. The lower face is treated with botulinum toxin to achieve a harmonious facial profile. Twenty young females ranging in age from 30 to 45 years consented and received the three-pronged procedure from March 2014 to April 2015; photography at baseline and follow-up visit were taken and analyzed. After posttreatment for 2 months, significant improvement was observed compared with the baseline. And the reduced masseter prominence and prominent chin were obtained, showing a favorable facial contour and harmonious appearance during the follow-up. The novel three-pronged approach to lower facial rejuvenation was aimed at the Asian characteristic of hypertrophic masseter, chin retrusion, and the facial sagging during the aging process. Botox treatment was a quite effective and safe strategy to improve the appearance and contour of the lower face in Asian patients.

* Renpeng Zhou and Benyun Pan contributed equally.


 
  • References

  • 1 Lorenc ZP, Smith S, Nestor M, Nelson D, Moradi A. Understanding the functional anatomy of the frontalis and glabellar complex for optimal aesthetic botulinum toxin type A therapy. Aesthetic Plast Surg 2013; 37 (5) 975-983
  • 2 Raspaldo H, Baspeyras M, Bellity P , et al; Consensus Group. Upper- and mid-face anti-aging treatment and prevention using onabotulinum toxin A: the 2010 multidisciplinary French consensus--part 1. J Cosmet Dermatol 2011; 10 (1) 36-50
  • 3 Moers-Carpi M, Carruthers J, Fagien S , et al. Efficacy and safety of onabotulinumtoxinA for treating crow's feet lines alone or in combination with glabellar lines: a multicenter, randomized, controlled trial. Dermatol Surg 2015; 41 (1) 102-112
  • 4 Atamoros FP. Botulinum toxin in the lower one third of the face. Clin Dermatol 2003; 21 (6) 505-512
  • 5 Kim NH, Chung JH, Park RH, Park JB. The use of botulinum toxin type A in aesthetic mandibular contouring. Plast Reconstr Surg 2005; 115 (3) 919-930
  • 6 Yu CC, Chen PK, Chen YR. Botulinum toxin a for lower facial contouring: a prospective study. Aesthetic Plast Surg 2007; 31 (5) 445-451 , discussion 452–453
  • 7 Lowe NJ, Yamauchi P. Cosmetic uses of botulinum toxins for lower aspects of the face and neck. Clin Dermatol 2004; 22 (1) 18-22
  • 8 Kim NH, Park RH, Park JB. Botulinum toxin type A for the treatment of hypertrophy of the masseter muscle. Plast Reconstr Surg 2010; 125 (6) 1693-1705
  • 9 Hur MS, Kim HJ, Choi BY, Hu KS, Kim HJ, Lee KS. Morphology of the mentalis muscle and its relationship with the orbicularis oris and incisivus labii inferioris muscles. J Craniofac Surg 2013; 24 (2) 602-604
  • 10 Khan HA, Bagheri S. Surgical anatomy of the superficial musculo-aponeurotic system (SMAS). Atlas Oral Maxillofac Surg Clin North Am 2014; 22 (1) 9-15
  • 11 Hur MS, Hu KS, Cho JY , et al. Topography and location of the depressor anguli oris muscle with a reference to the mental foramen. Surg Radiol Anat 2008; 30 (5) 403-407
  • 12 Wu WT, Liew S, Chan HH , et al; Asian Facial Aesthetics Expert Consensus Group. Consensus on current injectable treatment strategies in the Asian face. Aesthetic Plast Surg 2016; 40 (2) 202-214
  • 13 Ahn J, Horn C, Blitzer A. Botulinum toxin for masseter reduction in Asian patients. Arch Facial Plast Surg 2004; 6 (3) 188-191
  • 14 Guyuron B. Precision rhinoplasty. Part I: The role of life-size photographs and soft-tissue cephalometric analysis. Plast Reconstr Surg 1988; 81 (4) 489-499
  • 15 Raspaldo H, Niforos FR, Gassia V , et al; Consensus Group. Lower-face and neck antiaging treatment and prevention using onabotulinum toxin A: the 2010 multidisciplinary French consensus--part 2. J Cosmet Dermatol 2011; 10 (2) 131-149
  • 16 Wu DC, Fabi SG, Goldman MP. Neurotoxins: current concepts in cosmetic use on the face and neck--lower face. Plast Reconstr Surg 2015; 136 (5) 76S-79S
  • 17 Liew S, Wu WT, Chan HH , et al. Consensus on changing trends, attitudes, and concepts of Asian beauty. Aesthetic Plast Surg 2016; 40 (2) 193-201
  • 18 Castello MF, Lazzeri D, Silvestri A , et al. Modified superficial musculoaponeurotic system face-lift: a review of 327 consecutive procedures and a patient satisfaction assessment. Aesthetic Plast Surg 2011; 35 (2) 147-155
  • 19 Lin J, Chen X. Modified technique of chin augmentation with MEDPOR for Asian patients. Aesthet Surg J 2012; 32 (7) 799-803
  • 20 Stephan F, Habre M, Tomb R. Clinical resistance to three types of botulinum toxin type A in aesthetic medicine. J Cosmet Dermatol 2014; 13 (4) 346-348
  • 21 Dressler D, Wohlfahrt K, Meyer-Rogge E, Wiest L, Bigalke H. Antibody-induced failure of botulinum toxin a therapy in cosmetic indications. Dermatol Surg 2010; 36 (Suppl. 04) 2182-2187
  • 22 Gaofeng L, Jun T, Bo P, Bosheng Z, Qian Z, Dongping L. Evaluation and selecting indications for the treatment of improving facial morphology by masseteric injection of botulinum toxin type A. J Plast Reconstr Aesthet Surg 2010; 63 (12) 2026-2031
  • 23 No YA, Ahn BH, Kim BJ, Kim MN, Hong CK. Three-dimensional CT might be a potential evaluation modality in correction of asymmetrical masseter muscle hypertrophy by botulinum toxin injection. J Cosmet Laser Ther 2016; 18 (2) 113-115
  • 24 Shim WH, Yoon SH, Park JH, Choi YC, Kim ST. Effect of botulinum toxin type A injection on lower facial contouring evaluated using a three-dimensional laser scan. Dermatol Surg 2010; 36 (Suppl. 04) 2161-2166
  • 25 Lee HH, Kim ST, Lee KJ, Baik HS. Effect of a second injection of botulinum toxin on lower facial contouring, as evaluated using 3-dimensional laser scanning. Dermatol Surg 2015; 41 (4) 439-444
  • 26 de Menezes M, Rosati R, Ferrario VF, Sforza C. Accuracy and reproducibility of a 3-dimensional stereophotogrammetric imaging system. J Oral Maxillofac Surg 2010; 68 (9) 2129-2135
  • 27 Gerth DJ, King B, Rabach L, Glasgold RA, Glasgold MJ. Long-term volumetric retention of autologous fat grafting processed with closed-membrane filtration. Aesthet Surg J 2014; 34 (7) 985-994